Ohcanbohtosat - Can Cai

  • Čájehuvvo 1 - 5 / 5
Aiddostahte ozu
  1. 1
    SVM-Prot: web-based support vector machine software for functional classification of a protein from its primary sequence

    SVM-Prot: web-based support vector machine software for functional classification of a protein from its primary sequence Dahkki Can Cai

    Almmustuhtton 2003
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine

    Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine Dahkki Edith A. Perez, Guillermo Lerzo, Xavier Pivot, Eva Thomas, Linda T. Vahdat, Linda D. Bosserman, Patrice Viens, Can Cai, Brian P. Mullaney, Ronald Peck, Gabriel N. Hortobágyi

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development

    Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development Dahkki Kunlun He, Xiwen Zhu, Yan Liu, Chunmu Miao, Tao Wang, Peizhi Li, Lei Zhao, Yaxi Chen, Junhua Gong, Can Cai, Jinzheng Li, Shengwei Li, Xiong Z. Ruan, Jianping Gong

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial

    Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial Dahkki Robert J. Motzer, Camillo Porta, Nicholas J. Vogelzang, Cora N. Sternberg, Cezary Szczylik, Jakub Żołnierek, Christian Kollmannsberger, Sun Young Rha, Georg A. Bjarnason, Bohuslav Melichar, Ugo De Giorgi, Viktor Grünwald, Ian D. Davis, Jae‐Lyun Lee, Emilio Esteban, Gladys Urbanowitz, Can Cai, Matthew Squires, Mahtab Marker, Michael Shi, Bernard Escudier

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial

    Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial Dahkki Hongfei Duan, X. Chen, Z. Li, Yu Pang, Wei Jing, P. Liu, Ting Wu, Can Cai, Jie Shi, Ziwei Qin, H. Yin, Chao Qiu, C. Li, Yuqing Xia, W. Chen, Z. Ye, Z. Li, Guofeng Chen, Shengjun Wang, Ying Liu, Luis Chu, Min Zhu, Tao Xu, Qi Wang, Jie Wang, Yue Du, Jie Wang, Naihui Chu, Steven Jing‐Liang Xu

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: